The label change that weight-loss drug companies are cashing in on While a GLP-1 friendly label may seem arbitrary, some medical experts say it may make people pay closer attention to what theyre eating Bookmark CommentsGo to comments Food manufacturers are trying to cash in on the popularity of weight-loss medications such as Ozempic and Mounjaro, with a growing number of easy, grab-and-go meals and snacks being sold as GLP-1 friendly. These labels might highlight that a meal or snack is higher in protein and fiber, or simply a smaller portion size than other options although consumers should be skeptical of any health benefits, experts say
These studies effectively confirmed the critical regulatory role of the IGF-1/IGF-1R/MAPK signaling axis in malignant tumor progression
The molecule was first developed in the 1980s by University of Arizona researchers, who were looking to clarify the nature and role of the melanocortin receptors in physiological functions
This inactivates GLP-1 as an intact N-terminal end is required for binding to its receptor [13]
According to available research, the two most effective licensed treatments available currently are Wegovy and Zepbound
This is the process known to be responsible for significant damage to - and premature aging of - our cells